the evolving adult immunization platform
Download
Skip this Video
Download Presentation
The Evolving Adult Immunization Platform

Loading in 2 Seconds...

play fullscreen
1 / 19

The Evolving Adult Immunization Platform - PowerPoint PPT Presentation


  • 111 Views
  • Uploaded on

The Evolving Adult Immunization Platform. William Schaffner, MD Vanderbilt University School of Medicine Nashville, TN. When meditating over a disease, I never think of finding a remedy for it, but, instead, a means of preventing it. Louis Pasteur

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'The Evolving Adult Immunization Platform' - metea


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
the evolving adult immunization platform

The Evolving AdultImmunization Platform

William Schaffner, MD

Vanderbilt University School of Medicine

Nashville, TN

slide2

When meditating over a disease,

I never think of finding a remedy for it,

but, instead, a means of preventing it.

Louis Pasteur

(1822-1895)

slide3

Infant/Childhood immunization – one of the top public health success stories of the 20th century

Diphtheria, tetanus, measles, mumps, rubella, polio, H. influenzae B, hepatitis B reduced by over 99%

Pertussis, hepatitis A, select pneumococcal, varicella, rotavirus, influenza being reduced

invigoration of adult immunization
Invigoration of Adult Immunization
  • Build on success of infant/childhood, adolescent program
  • New vaccines targeted at adults
  • Recognition of the burden of adult vaccine-preventable disease
burden of adult vaccine preventable disease
Burden of Adult Vaccine-Preventable Disease

Influenza: 10-20% of US population affected annually

200,000 hospitalizations

36,000 deaths (average)

Pneumococcal: 2,000-5000 meningitis

40,000+ bloodstream infections

150,000-300,000 pneumonia

Pertussis: 1 million

Cervical cancer: 10,000

Shingles: 1 million

Adult deaths from vaccine-preventable diseases: 43,000

reported pertussis cases
Reported Pertussis Cases

≥ 19 yrs

11–18 yrs

< 11 yrs

Reported Pertussis Cases

  • 2004 provisional data
tdap vaccine tetanus diphtheria acellular pertussis
Tdap VaccineTetanus-Diphtheria – acellular Pertussis

Licensed as one-time booster dose through age 64

Use Tdap at time of regular 10-year booster

  • Individual protection against pertussis, tetanus, diphtheria
  • Reduce community outbreaks
  • Interrupt transmission to vulnerable infants by vaccinating adults (cocoon)
human papillomavirus vaccine cervical cancer
Human Papillomavirus Vaccine(Cervical Cancer)
  • Licensed vaccine against 4 virus types (6, 11, 16, 18) for females 9-26 years
  • Papillomavirus infection is precursor to cervical cancer
    • Types 16, 18 account for 70% of cervical cancers
  • Virus is transmitted by sexual contact
    • Over half of women are infected during their lifetime
  • Three-dose series
natural history of hpv infection and potential progression to cervical cancer 1
Natural History of HPV Infection and Potential Progression to Cervical Cancer1

0–1 Year

0–5 Years

1–20 Years

Invasive Cervical Cancer

InitialHPV Infection

ContinuingInfection

CIN 2/3

CIN 1

Cleared HPV Infection (~80%)

1. Pinto AP, Crum CP. Clin Obstet Gynecol. 2000;43:352–362.

hpv vaccine trial
HPV Vaccine Trial
  • Randomized, placebo-controlled, double blind
  • 27,000 volunteers
  • 100% effective vs. CIN 2/3
human papillomavirus vaccine
Human Papillomavirus Vaccine

CDC’s Advisory Committee on Immunization Practices (ACIP) June 29, 2006

Recommendations:

  • Routine immunization of females at 11-12 years
  • May be started as young as 9 years at discretion of provider/parent
  • Vaccination of females up to age 26
herpes zoster shingles vaccine
Herpes Zoster (shingles) Vaccine
  • Licensed for persons 60+ years of age
  • Shingles – localized rash due to reactivation of latent chickenpox (varicella) virus
  • Post-Shingles pain – extreme, debilitating pain lasting for months
  • Vaccine licensed for persons 60+ years of age
    • High potency live, attenuated varicella vaccine
    • Boosts immunity
shingles prevention study 1
Shingles Prevention Study - 1
  • Randomized, placebo-controlled, double blind vaccine trial
  • 38,546 volunteers at 22 sites; adults 60+
shingles prevention study 2
Shingles Prevention Study - 2
  • 95% of volunteers completed study
  • Follow-up <1 - 4.9 years; average 3 years
  • Shingles reduced 51%
    • 60-69 years 64%
    • 70-79 years 41%
    • 80+ 18%
  • Post-shingles pain: 67%
reported acute hepatitis b incidence by age group united states 1990 2004
Reported Acute Hepatitis B Incidence By Age Group: United States, 1990-2004

≥20 years

94% decline

71% decline

12-19 years

Cases per 100,000

<12 years

Year

reported acute hepatitis b incidence by age and sex united states 2004
Reported Acute Hepatitis B Incidence By Age and Sex: United States, 2004

0.1

0.1

<5

Female

Male

0.0

0.1

5-9

0.1

0.1

10-14

1.1

0.4

15-19

3.1

3.1

20-24

5.2

4.2

25-29

4.9

4.0

30-34

Age Group (Yrs)

4.4

5.4

35-39

3.6

4.9

40-44

2.7

4.0

45-49

2.0

3.2

50-54

1.3

2.9

55-59

0.8

1.4

60+

Rate per 100,000

hepatitis b vaccine acip recommendations
Hepatitis B Vaccine: ACIP Recommendations

Expanded Risk Groups

Sexual Transmission

  • All sexually active persons not in a mutually monogamous relationship
  • Persons evaluated or treated for STDs
  • Men who have sex with men
  • Sex partners of HBsAg-positive persons
adult immunization
Adult Immunization

Influenza Tdap

Pneumococcal HPV (cervical cancer)

Hepatitis BShingles

Special circumstances, e.g. Travel, Health Care Worker

adult immunization challenges
Adult Immunization Challenges
  • Inadequate payment for vaccines and administration in both public programs and private medical insurance
  • Lack of knowledge – both patients and providers
  • Poor public health and private infrastructure for vaccine delivery
ad